{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:45:29Z","timestamp":1792115129464,"version":"4.4.0"},"reference-count":54,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T00:00:00Z","timestamp":1565222400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1804281"],"award-info":[{"award-number":["U1804281"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771781"],"award-info":[{"award-number":["81771781"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602024"],"award-info":[{"award-number":["81602024"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["j. immunotherapy cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40425-019-0701-2","type":"journal-article","created":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T12:02:47Z","timestamp":1565265767000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":221,"title":["Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1\/CEBPB\/NF-\u03baB signaling"],"prefix":"10.1136","volume":"7","author":[{"given":"Dan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weina","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyao","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aitian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenqiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weitang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9861-4681","authenticated-orcid":false,"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,8,8]]},"reference":[{"key":"701_CR1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1186\/s12885-016-2475-y","volume":"16","author":"JM Quintana","year":"2016","unstructured":"Quintana JM, Gonzalez N, Anton-Ladislao A, Redondo M, Bare M, Fernandez de Larrea N, Briones E, Escobar A, Sarasqueta C, Garcia-Gutierrez S, et al. Colorectal cancer health services research study protocol: the CCR-CARESS observational prospective cohort project. BMC Cancer. 2016;16:435.","journal-title":"BMC Cancer"},{"key":"701_CR2","doi-asserted-by":"publisher","first-page":"6876","DOI":"10.3748\/wjg.v22.i30.6876","volume":"22","author":"T Hu","year":"2016","unstructured":"Hu T, Li Z, Gao CY, Cho CH. Mechanisms of drug resistance in colon cancer and its therapeutic strategies. World J Gastroenterol. 2016;22:6876\u201389.","journal-title":"World J Gastroenterol"},{"key":"701_CR3","first-page":"1343","volume":"53","author":"P Su","year":"2018","unstructured":"Su P, Yang Y, Wang G, Chen X, Ju Y. Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells. Int J Oncol. 2018;53:1343\u201353.","journal-title":"Int J Oncol"},{"key":"701_CR4","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nrclinonc.2012.129","volume":"9","author":"MT Villanueva","year":"2012","unstructured":"Villanueva MT. Cell signalling: stuck in the middle of chemoresistance and metastasis. Nat Rev Clin Oncol. 2012;9:490.","journal-title":"Nat Rev Clin Oncol"},{"key":"701_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.breast.2016.09.002","volume":"30","author":"K Velaei","year":"2016","unstructured":"Velaei K, Samadi N, Barazvan B, Soleimani RJ. Tumor microenvironment-mediated chemoresistance in breast cancer. Breast. 2016;30:92\u2013100.","journal-title":"Breast."},{"key":"701_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cytogfr.2017.05.003","volume":"36","author":"L Fattore","year":"2017","unstructured":"Fattore L, Sacconi A, Mancini R, Ciliberto G. MicroRNA-driven deregulation of cytokine expression helps development of drug resistance in metastatic melanoma. Cytokine Growth Factor Rev. 2017;36:39\u201348.","journal-title":"Cytokine Growth Factor Rev"},{"key":"701_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s40425-019-0611-3","volume":"7","author":"P Dama","year":"2019","unstructured":"Dama P, Tang M, Fulton N, Kline J, Liu H. Gal9\/Tim-3 expression level is higher in AML patients who fail chemotherapy. J Immunotherapy Cancer. 2019;7:175.","journal-title":"J Immunotherapy Cancer."},{"key":"701_CR8","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1158\/2326-6066.CIR-14-0244","volume":"3","author":"XD Liu","year":"2015","unstructured":"Liu XD, Hoang A, Zhou L, Kalra S, Yetil A, Sun M, Ding Z, Zhang X, Bai S, German P, et al. Resistance to antiangiogenic therapy is associated with an immunosuppressive tumor microenvironment in metastatic renal cell carcinoma. Cancer Immunol Res. 2015;3:1017\u201329.","journal-title":"Cancer Immunol Res"},{"key":"701_CR9","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.3389\/fimmu.2018.01186","volume":"9","author":"C Perrotta","year":"2018","unstructured":"Perrotta C, Cervia D, Di Renzo I, Moscheni C, Bassi MT, Campana L, Martelli C, Catalani E, Giovarelli M, Zecchini S, et al. Nitric oxide generated by tumor-associated macrophages is responsible for Cancer resistance to cisplatin and correlated with Syntaxin 4 and acid sphingomyelinase inhibition. Front Immunol. 2018;9:1186.","journal-title":"Front Immunol"},{"key":"701_CR10","doi-asserted-by":"publisher","first-page":"4462","DOI":"10.1038\/sj.onc.1208621","volume":"24","author":"TN Hartmann","year":"2005","unstructured":"Hartmann TN, Burger JA, Glodek A, Fujii N, Burger M. CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells. Oncogene. 2005;24:4462\u201371.","journal-title":"Oncogene."},{"key":"701_CR11","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1158\/1078-0432.CCR-15-2888","volume":"23","author":"AA Calinescu","year":"2017","unstructured":"Calinescu AA, Yadav VN, Carballo E, Kadiyala P, Tran D, Zamler DB, Doherty R, Srikanth M, Lowenstein PR, Castro MG. Survival and proliferation of neural progenitor-derived glioblastomas under hypoxic stress is controlled by a CXCL12\/CXCR4 autocrine-positive feedback mechanism. Clin Cancer Res. 2017;23:1250\u201362.","journal-title":"Clin Cancer Res"},{"key":"701_CR12","doi-asserted-by":"publisher","first-page":"E1291","DOI":"10.1073\/pnas.1220580110","volume":"110","author":"M Gil","year":"2013","unstructured":"Gil M, Seshadri M, Komorowski MP, Abrams SI, Kozbor D. Targeting CXCL12\/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases. Proc Natl Acad Sci U S A. 2013;110:E1291\u2013300.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"701_CR13","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1158\/1078-0432.CCR-08-1588","volume":"15","author":"YH Park","year":"2009","unstructured":"Park YH, Sohn SK, Kim JG, Lee MH, Song HS, Kim MK, Jung JS, Lee JJ, Kim HJ, Kim DH. Interaction between BCL2 and interleukin-10 gene polymorphisms alter outcomes of diffuse large B-cell lymphoma following rituximab plus CHOP chemotherapy. Clinical Cancer Res. 2009;15:2107\u201315.","journal-title":"Clinical Cancer Res"},{"key":"701_CR14","doi-asserted-by":"publisher","first-page":"6323","DOI":"10.1073\/pnas.1401799111","volume":"111","author":"JL Heinecke","year":"2014","unstructured":"Heinecke JL, Ridnour LA, Cheng RY, Switzer CH, Lizardo MM, Khanna C, Glynn SA, Hussain SP, Young HA, Ambs S, et al. Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression. Proc Natl Acad Sci U S A. 2014;111:6323\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"701_CR15","doi-asserted-by":"publisher","first-page":"6716","DOI":"10.1158\/1078-0432.CCR-13-0842","volume":"19","author":"HK Bid","year":"2013","unstructured":"Bid HK, Kibler A, Phelps DA, Manap S, Xiao L, Lin J, Capper D, Oswald D, Geier B, DeWire M, et al. Development, characterization, and reversal of acquired resistance to the MEK1 inhibitor selumetinib (AZD6244) in an in vivo model of childhood astrocytoma. Clin Cancer Res. 2013;19:6716\u201329.","journal-title":"Clin Cancer Res"},{"key":"701_CR16","doi-asserted-by":"publisher","first-page":"6125","DOI":"10.1158\/1078-0432.CCR-10-2743","volume":"17","author":"H Korkaya","year":"2011","unstructured":"Korkaya H, Liu S, Wicha MS. Regulation of cancer stem cells by cytokine networks: attacking cancer's inflammatory roots. Clin Cancer Res. 2011;17:6125\u20139.","journal-title":"Clin Cancer Res"},{"key":"701_CR17","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/onc.2017.387","volume":"37","author":"Y Qiao","year":"2018","unstructured":"Qiao Y, Zhang C, Li A, Wang D, Luo Z, Ping Y, Zhou B, Liu S, Li H, Yue D, et al. IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma. Oncogene. 2018;37:873\u201383.","journal-title":"Oncogene."},{"key":"701_CR18","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1002\/ijc.30289","volume":"139","author":"L Li","year":"2016","unstructured":"Li L, Yang L, Wang L, Wang F, Zhang Z, Li J, Yue D, Chen X, Ping Y, Huang L, et al. Impaired T cell function in malignant pleural effusion is caused by TGF-beta derived predominantly from macrophages. Int J Cancer. 2016;139:2261\u20139.","journal-title":"Int J Cancer"},{"key":"701_CR19","doi-asserted-by":"publisher","first-page":"367ra166","DOI":"10.1126\/scitranslmed.aag3187","volume":"8","author":"N Arenas-Ramirez","year":"2016","unstructured":"Arenas-Ramirez N, Zou C, Popp S, Zingg D, Brannetti B, Wirth E, Calzascia T, Kovarik J, Sommer L, Zenke G, et al. Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2. Sci Translational Med. 2016;8:367ra166.","journal-title":"Sci Translational Med"},{"key":"701_CR20","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1038\/leu.2008.224","volume":"22","author":"T Krejsgaard","year":"2008","unstructured":"Krejsgaard T, Gjerdrum LM, Ralfkiaer E, Lauenborg B, Eriksen KW, Mathiesen AM, Bovin LF, Gniadecki R, Geisler C, Ryder LP, et al. Malignant Tregs express low molecular splice forms of FOXP3 in Sezary syndrome. Leukemia. 2008;22:2230\u20139.","journal-title":"Leukemia."},{"key":"701_CR21","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1053\/j.gastro.2016.02.040","volume":"150","author":"SL Zhou","year":"2016","unstructured":"Zhou SL, Zhou ZJ, Hu ZQ, Huang XW, Wang Z, Chen EB, Fan J, Cao Y, Dai Z, Zhou J. Tumor-associated neutrophils recruit macrophages and T-regulatory cells to promote progression of hepatocellular carcinoma and resistance to Sorafenib. Gastroenterology. 2016;150:1646\u201358 e17.","journal-title":"Gastroenterology."},{"key":"701_CR22","doi-asserted-by":"crossref","first-page":"175883591878313","DOI":"10.1177\/1758835918783132","volume":"10","author":"DQ Chen","year":"2018","unstructured":"Chen DQ, Yu C, Zhang XF, Liu ZF, Wang R, Jiang M, Chen H, Yan F, Tao M, Chen LB, et al. HDAC3-mediated silencing of miR-451 decreases chemosensitivity of patients with metastatic castration-resistant prostate cancer by targeting NEDD9. Therapeutic Adv Med Oncol. 2018;10:1758835918783132.","journal-title":"Therapeutic Adv Med Oncol"},{"key":"701_CR23","doi-asserted-by":"crossref","first-page":"28116","DOI":"10.18632\/oncotarget.25565","volume":"9","author":"C Angelucci","year":"2018","unstructured":"Angelucci C, D'Alessio A, Lama G, Binda E, Mangiola A, Vescovi AL, Proietti G, Masuelli L, Bei R, Fazi B, et al. Cancer stem cells from peritumoral tissue of glioblastoma multiforme: the possible missing link between tumor development and progression. Oncotarget. 2018;9:28116\u201330.","journal-title":"Oncotarget."},{"key":"701_CR24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.tranon.2017.12.009","volume":"11","author":"J Gyamfi","year":"2018","unstructured":"Gyamfi J, Eom M, Koo JS, Choi J. Multifaceted roles of Interleukin-6 in adipocyte-breast Cancer cell interaction. Transl Oncol. 2018;11:275\u201385.","journal-title":"Transl Oncol"},{"key":"701_CR25","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1186\/s12885-017-3750-2","volume":"17","author":"RM Nair","year":"2017","unstructured":"Nair RM, Balla MM, Khan I, Kalathur RKR, Kondaiah P, Vemuganti GK. In vitro characterization of CD133(lo) cancer stem cells in retinoblastoma Y79 cell line. BMC Cancer. 2017;17:779.","journal-title":"BMC Cancer"},{"key":"701_CR26","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.tranon.2017.07.007","volume":"10","author":"Y Sun","year":"2017","unstructured":"Sun Y, Yoshida T, Okabe M, Zhou K, Wang F, Soko C, Saito S, Nikaido T. Isolation of stem-like Cancer cells in primary endometrial Cancer using cell surface markers CD133 and CXCR4. Transl Oncol. 2017;10:976\u201387.","journal-title":"Transl Oncol"},{"key":"701_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10\u201329.","journal-title":"CA Cancer J Clin"},{"key":"701_CR28","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/bjs.5349","volume":"93","author":"S Manfredi","year":"2006","unstructured":"Manfredi S, Bouvier AM, Lepage C, Hatem C, Dancourt V, Faivre J. Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. Br J Surg. 2006;93:1115\u201322.","journal-title":"Br J Surg"},{"key":"701_CR29","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/33340","volume":"392","author":"M Baggiolini","year":"1998","unstructured":"Baggiolini M. Chemokines and leukocyte traffic. Nature. 1998;392:565\u20138.","journal-title":"Nature."},{"key":"701_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40425-019-0511-6","volume":"7","author":"Q Gao","year":"2019","unstructured":"Gao Q, Wang S, Chen X, Cheng S, Zhang Z, Li F, Huang L, Yang Y, Zhou B, Yue D, et al. Cancer-cell-secreted CXCL11 promoted CD8(+) T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC. J Immunother Cancer. 2019;7:42.","journal-title":"J Immunother Cancer"},{"key":"701_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40425-016-0125-1","volume":"4","author":"I Siddiqui","year":"2016","unstructured":"Siddiqui I, Erreni M, van Brakel M, Debets R, Allavena P. Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine\/CX3CL1 expressing tumors: importance of the chemokine gradient. J Immunother cancer. 2016;4:21.","journal-title":"J Immunother cancer"},{"key":"701_CR32","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nature17403","volume":"532","author":"L Seifert","year":"2016","unstructured":"Seifert L, Werba G, Tiwari S, Giao Ly NN, Alothman S, Alqunaibit D, Avanzi A, Barilla R, Daley D, Greco SH, et al. The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression. Nature. 2016;532:245\u20139.","journal-title":"Nature."},{"key":"701_CR33","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1158\/2326-6066.CIR-18-0045","volume":"6","author":"J Yang","year":"2018","unstructured":"Yang J, Kumar A, Vilgelm AE, Chen SC, Ayers GD, Novitskiy SV, Joyce S, Richmond A. Loss of CXCR4 in myeloid cells enhances antitumor immunity and reduces melanoma growth through NK cell and FASL mechanisms. Cancer Immunol Res. 2018;6:1186\u201398.","journal-title":"Cancer Immunol Res"},{"key":"701_CR34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/hep.30134","volume":"69","author":"LZ Liu","year":"2019","unstructured":"Liu LZ, Zhang Z, Zheng BH, Shi Y, Duan M, Ma LJ, Wang ZC, Dong LQ, Dong PP, Shi JY, et al. CCL15 recruits suppressive monocytes to facilitate immune escape and disease progression in hepatocellular carcinoma. Hepatology. 2019;69:143\u201359.","journal-title":"Hepatology."},{"key":"701_CR35","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nature08782","volume":"464","author":"M Ammirante","year":"2010","unstructured":"Ammirante M, Luo JL, Grivennikov S, Nedospasov S, Karin M. B-cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature. 2010;464:302\u20135.","journal-title":"Nature."},{"key":"701_CR36","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1101\/gad.220202.113","volume":"27","author":"M Ammirante","year":"2013","unstructured":"Ammirante M, Kuraishy AI, Shalapour S, Strasner A, Ramirez-Sanchez C, Zhang W, Shabaik A, Karin M. An IKKalpha-E2F1-BMI1 cascade activated by infiltrating B cells controls prostate regeneration and tumor recurrence. Genes Dev. 2013;27:1435\u201340.","journal-title":"Genes Dev"},{"key":"701_CR37","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1158\/0008-5472.CAN-16-1755","volume":"77","author":"SM Steinberg","year":"2017","unstructured":"Steinberg SM, Shabaneh TB, Zhang P, Martyanov V, Li Z, Malik BT, Wood TA, Boni A, Molodtsov A, Angeles CV, et al. Myeloid cells that impair immunotherapy are restored in melanomas with acquired resistance to BRAF inhibitors. Cancer Res. 2017;77:1599\u2013610.","journal-title":"Cancer Res"},{"key":"701_CR38","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1172\/JCI93182","volume":"127","author":"K Jung","year":"2017","unstructured":"Jung K, Heishi T, Khan OF, Kowalski PS, Incio J, Rahbari NN, Chung E, Clark JW, Willett CG, Luster AD, et al. Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy. J Clin Invest. 2017;127:3039\u201351.","journal-title":"J Clin Invest"},{"key":"701_CR39","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1159\/000495903","volume":"51","author":"C Zhao","year":"2018","unstructured":"Zhao C, Wang D, Tang L, Zhang Z, Li S, Qian M, Wu Z, Zhou W, Liu M, Luo J, et al. Stromal cell-derived CCL20 promotes tumor progression and Osteolysis in Giant cell tumor of bone. Cell Physiol Biochem. 2018;51:2472\u201383.","journal-title":"Cell Physiol Biochem"},{"key":"701_CR40","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.yexcr.2018.09.023","volume":"372","author":"M Benkheil","year":"2018","unstructured":"Benkheil M, Van Haele M, Roskams T, Laporte M, Noppen S, Abbasi K, Delang L, Neyts J, Liekens S. CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): potential role in HCV-related liver cancer. Exp Cell Res. 2018;372:168\u201377.","journal-title":"Exp Cell Res"},{"issue":"3","key":"701_CR41","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1158\/2326-6066.CIR-17-0198","volume":"6","author":"Rafael Samaniego","year":"2018","unstructured":"Samaniego R, Gutierrez-Gonzalez A, Gutierrez-Seijo A, Sanchez-Gregorio S, Garcia-Gimenez J, Mercader E, Marquez-Rodas I, Aviles JA, Relloso M, Sanchez-Mateos P. CCL20 expression by tumor-associated macrophages predicts progression of human primary cutaneous melanoma. Cancer Immunol Res. 2018;6:267-75.","journal-title":"Cancer Immunology Research"},{"key":"701_CR42","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.biopha.2016.11.055","volume":"85","author":"E Lu","year":"2017","unstructured":"Lu E, Su J, Zhou Y, Zhang C, Wang Y. CCL20\/CCR6 promotes cell proliferation and metastasis in laryngeal cancer by activating p38 pathway. Biomed Pharmacother. 2017;85:486\u201392.","journal-title":"Biomed Pharmacother"},{"key":"701_CR43","doi-asserted-by":"publisher","first-page":"5248","DOI":"10.1158\/0008-5472.CAN-15-0732","volume":"75","author":"B Walch-Ruckheim","year":"2015","unstructured":"Walch-Ruckheim B, Mavrova R, Henning M, Vicinus B, Kim YJ, Bohle RM, Juhasz-Boss I, Solomayer EF, Smola S. Stromal fibroblasts induce CCL20 through IL6\/C\/EBPbeta to support the recruitment of Th17 cells during cervical Cancer progression. Cancer Res. 2015;75:5248\u201359.","journal-title":"Cancer Res"},{"key":"701_CR44","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1158\/0008-5472.CAN-15-0054","volume":"75","author":"L Benevides","year":"2015","unstructured":"Benevides L, da Fonseca DM, Donate PB, Tiezzi DG, De Carvalho DD, de Andrade JM, Martins GA, Silva JS. IL17 promotes mammary tumor progression by changing the behavior of tumor cells and eliciting tumorigenic neutrophils recruitment. Cancer Res. 2015;75:3788\u201399.","journal-title":"Cancer Res"},{"key":"701_CR45","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00018-015-2112-y","volume":"73","author":"A Coomans de Brachene","year":"2016","unstructured":"Coomans de Brachene A, Demoulin JB. FOXO transcription factors in cancer development and therapy. Cell Mol Life Sci. 2016;73:1159\u201372.","journal-title":"Cell Mol Life Sci"},{"key":"701_CR46","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.canlet.2016.03.005","volume":"375","author":"DJ Barakat","year":"2016","unstructured":"Barakat DJ, Mendonca J, Barberi T, Zhang J, Kachhap SK, Paz-Priel I, Friedman AD. C\/EBPbeta regulates sensitivity to bortezomib in prostate cancer cells by inducing REDD1 and autophagosome-lysosome fusion. Cancer Lett. 2016;375:152\u201361.","journal-title":"Cancer Lett"},{"key":"701_CR47","doi-asserted-by":"publisher","first-page":"26013","DOI":"10.18632\/oncotarget.14847","volume":"8","author":"JD Gardiner","year":"2017","unstructured":"Gardiner JD, Abegglen LM, Huang X, Carter BE, Schackmann EA, Stucki M, Paxton CN, Lor Randall R, Amatruda JF, Putnam AR, et al. C\/EBPbeta-1 promotes transformation and chemoresistance in Ewing sarcoma cells. Oncotarget. 2017;8:26013\u201326.","journal-title":"Oncotarget."},{"key":"701_CR48","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jnutbio.2018.09.022","volume":"63","author":"G Muthusamy","year":"2019","unstructured":"Muthusamy G, Gunaseelan S, Prasad NR. Ferulic acid reverses P-glycoprotein-mediated multidrug resistance via inhibition of PI3K\/Akt\/NF-kappaB signaling pathway. J Nutr Biochem. 2019;63:62\u201371.","journal-title":"J Nutr Biochem"},{"key":"701_CR49","doi-asserted-by":"publisher","first-page":"a000141","DOI":"10.1101\/cshperspect.a000141","volume":"1","author":"M Karin","year":"2009","unstructured":"Karin M. NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol. 2009;1:a000141.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"701_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2012.35","volume":"1","author":"A Arlt","year":"2012","unstructured":"Arlt A, Schafer H, Kalthoff H. The 'N-factors' in pancreatic cancer: functional relevance of NF-kappaB, NFAT and Nrf2 in pancreatic cancer. Oncogenesis. 2012;1:e35.","journal-title":"Oncogenesis."},{"key":"701_CR51","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.canlet.2010.10.015","volume":"332","author":"A Arlt","year":"2013","unstructured":"Arlt A, Muerkoster SS, Schafer H. Targeting apoptosis pathways in pancreatic cancer. Cancer Lett. 2013;332:346\u201358.","journal-title":"Cancer Lett"},{"key":"701_CR52","first-page":"4020","volume":"16","author":"C Lang","year":"2018","unstructured":"Lang C, Xu M, Zhao Z, Chen J, Zhang L. MicroRNA-96 expression induced by low-dose cisplatin or doxorubicin regulates chemosensitivity, cell death and proliferation in gastric cancer SGC7901 cells by targeting FOXO1. Oncol Lett. 2018;16:4020\u20136.","journal-title":"Oncol Lett"},{"key":"701_CR53","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1172\/JCI29401","volume":"116","author":"R Piva","year":"2006","unstructured":"Piva R, Pellegrino E, Mattioli M, Agnelli L, Lombardi L, Boccalatte F, Costa G, Ruggeri BA, Cheng M, Chiarle R, et al. Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes. J Clin Invest. 2006;116:3171\u201382.","journal-title":"J Clin Invest"},{"key":"701_CR54","first-page":"4516","volume":"21","author":"HY Xu","year":"2017","unstructured":"Xu HY, Fang W, Huang ZW, Lu JC, Wang YQ, Tang QL, Song GH, Kang Y, Zhu XJ, Zou CY, et al. Metformin reduces SATB2-mediated osteosarcoma stem cell-like phenotype and tumor growth via inhibition of N-cadherin\/NF-kB signaling. Eur Rev Med Pharmacol Sci. 2017;21:4516\u201328.","journal-title":"Eur Rev Med Pharmacol Sci"}],"updated-by":[{"DOI":"10.1136\/s40425-019-0701-2corr1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000}}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40425-019-0701-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40425-019-0701-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40425-019-0701-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T08:32:56Z","timestamp":1610785976000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1186\/s40425-019-0701-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,8]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["701"],"URL":"https:\/\/doi.org\/10.1186\/s40425-019-0701-2","relation":{"correction":[{"id-type":"doi","id":"10.1136\/s40425-019-0701-2corr1","asserted-by":"object"}]},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,8]]},"assertion":[{"value":"23 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The research protocol was reviewed and approved by the Ethics Committee of Zhengzhou University (Ethical approval number: Science-2010-LW-1213), and informed consent was obtained from all participants included in the study, in agreement with institutional guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"215"}}